Physician Assistant in Mt Pleasant, PA Accepting Medicare

8 Physician Assistant nurses found. Showing 1 - 8

Charles Smith, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 828 W Main St, Mt Pleasant, PA 15666 Phone: 724-547-4441

Mr. Christopher Ross Horrell, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 828 W Main St, Mt Pleasant, PA 15666 Phone: 724-547-4441

Amy E Schleifer, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 599 N Church St, Suite 200, Mt Pleasant, PA 15666 Phone: 724-542-5349    Fax: 724-542-4658

Lara H Blosser, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 508 S Church St, Mt Pleasant, PA 15666 Phone: 724-547-1500

Heather Marie Patterson, PA-C Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 828 West Main St, Mt Pleasant, PA 15666 Phone: 724-547-4411

Jacob P Crawford, Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 508 S Church St, Mt Pleasant, PA 15666 Phone: 724-547-1636    Fax: 724-547-1762

Mrs. Maureen L George, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 828 W Main St, Mt Pleasant, PA 15666 Phone: 724-547-4441    Fax: 724-547-4311

Kimberly Mcdowell, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 480 Eagle St, Mt Pleasant, PA 15666 Phone: 724-547-7212    Fax: 724-547-7278

News Archive

U.S. District Court grants Cephalon Temporary Restraining Order for generic AMRIX

Today, the United States District Court for the District of Delaware granted a motion filed by plaintiffs Cephalon, Inc., and Eurand, Inc., for a Temporary Restraining Order (TRO) enjoining Mylan Pharmaceuticals Inc., and Mylan Inc., from manufacturing, using, offering to sell or selling its cyclobenzaprine hydrochloride extended-release capsules, a generic version of Cephalon's branded product AMRIX.

ACTIV-3 clinical trial evaluating investigational COVID-19 therapies closes enrollment in two sub-studies

The ACTIV-3 clinical trial, which is evaluating the safety and efficacy of investigational therapeutics for COVID-19 in hospitalized patients, has closed enrollment in two sub-studies: one examining the investigational monoclonal antibody therapy VIR-7831, and another evaluating the investigational combination monoclonal antibody therapy containing BRII-196 and BRII-198.

Study highlights advantages of Baxano's iO-Flex system in performing lumbar spinal decompression

Baxano, Inc., the manufacturer of the innovative and cost-effective iO-Flex System, announced today the publication of a peer-reviewed study highlighting the advantages of the flagship iO-Flex

Phylogenetic analyses shows SARS-CoV-2 variant B.1.1.7 originated in the UK

It was also classified as a "Variant of Concern" (VOC B.1.1.7) in December 2020. First discovered in Kent, United Kingdom, in September 2020, this new variant has since been found in more than 29 countries across the globe, including the USA.

Wayne State researchers receive $1.9 million NIH grant to better understand rare genetic disorders

A team of Wayne State University researchers recently received a $1.9 million grant from the National Eye Institute of the National Institutes of Health to better understand leukodystrophies (LD) and genetic Leukoencephalopathies (gLE), rare genetic disorders affecting the white matter - myelin - in the central nervous system.

Read more Medical News

› Verified 1 days ago